封面
市場調查報告書
商品編碼
1482459

全球桑格定序市場:按類型、按應用、按最終用途、按地區

Global Sanger Sequencing Market, By Type, By Application, By End-use, and Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年全球桑格定序市場規模估計將達31.499億美元,2024年至2031年年複合成長率為18.2%,2031年將達101.306億美元。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 31.499 億美元
實際資料 2019-2023 預測期 2024-2031
預測2024-2031年年複合成長率: 18.20% 2031年金額預測 101.306 億美元
圖:2024年依地區分類的桑格定序全球市場佔有率(%)
全球桑格定序市場-IMG1

桑格定序,也稱為鏈終止或雙脫氧定序,是一種基於體外 DNA 複製過程中 DNA聚合酵素選擇性摻入鏈終止雙脫氧核苷酸的 DNA 定序技術。這項技術由英國生物化學家 Frederick Sanger 於 1977年開發,徹底改變了核酸定序,並促進了遺傳學和基因組學的快速發展。桑格定序可產生雙向高品質 DNA 序列,被認為是 DNA 定序的黃金標準。

市場動態:

全球桑格定序市場主要是由醫療保健、生物技術和學術研究等各行業對準確且經濟高效的 DNA 定序的需求不斷成長所推動。導致自動化和Qualcomm Incorporated量的持續技術進步日益擴大桑格定序的應用。例如,許多次世代定序平台利用短桑格讀取進行組裝。然而,高資本投資要求和複雜的工作流程為市場成長帶來了挑戰。新的定序技術可能會透過降低成本和增加產能來擾亂市場。也就是說,桑格定序預計將繼續在需要長而準確讀取的利基應用中發揮重要作用。市場參與企業正致力於透過合作研究擴大產品系列擴大地域範圍。

本研究的主要特點

  • 本報告對全球桑格定序市場進行了詳細分析,包括以2023年為基準年的預測期(2024-2031年)的市場規模(百萬美元)和年複合成長率(CAGR%)。
  • 它闡明了各個細分市場的潛在收益成長機會,並解釋了該市場有吸引力的投資提案矩陣。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點、財務表現和策略等參數,介紹了全球桑格定序市場的主要企業。
  • 本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球桑格定序市場迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球桑格定序市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 最近的趨勢
  • 監管場景
  • 製造商收益
  • 價格分析
  • 收購和合作場景
  • 產品發布/核准
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章 全球桑格定序市場 - COVID-19 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章 全球桑格定序市場:依類型分類,2019-2031(百萬美元)

  • 霰彈槍定序
  • 標靶基因定序
  • 其他

第6章 全球桑格定序市場:依應用分類,2019-2031(百萬美元)

  • 診斷
  • 個人化醫療
  • 法醫學
  • 其他

第7章 全球桑格定序市場:依最終用途分類,2019-2031年(百萬美元)

  • 政府研究所
  • 診斷實驗室
  • 製藥和生物技術公司
  • 其他

第8章 全球桑格定序市場:依地區分類,2019-2031(百萬美元)

第9章 競爭格局

  • 公司簡介
    • Eurofins Scientific
    • CeMIA
    • Fasteris SA
    • GENEWIZ
    • GenHunter Corporation
    • GenScript
    • LGC Biosearch Technologies
    • Nucleics
    • Quintara Biosciences
    • SciGenom Labs Pvt. Ltd
    • StarSEQ GmbH
    • Thermo Fisher Scientific Inc.
    • QIAGEN
    • Promega Corporation
    • Source BioScience

第10章 分析師建議

第11章 參考文獻與調查方法

簡介目錄
Product Code: CMI6927

Global sanger sequencing market is estimated to be valued at USD 3,149.9 Mn in 2024, and is expected to reach USD 10,130.6 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 18.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 3,149.9 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 18.20% 2031 Value Projection: US$ 10,130.6 Mn
Figure. Global Sanger Sequencing Market Share (%), By Region 2024
Global Sanger Sequencing Market - IMG1

Sanger sequencing, also known as chain termination or dideoxy sequencing, is a method for DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication. This technique, developed by a British biochemist, Mr. Frederick Sanger in 1977, revolutionized DNA sequencing and enabled rapid progress in genetics and genomics. Sanger sequencing produces high-quality DNA sequences in both directions and is considered the gold standard for DNA sequencing.

Market Dynamics:

The global sanger sequencing market is predominantly driven by the increasing demand for accurate and cost-effective DNA sequencing across various industries such as healthcare, biotechnology, academic research, etc. Continuous technological advancements leading to automation and higher throughput are expanding the applications of Sanger sequencing. For example, many next-generation sequencing platforms rely on short Sanger reads for assembly. However, high capital investment requirements and complex workflow pose challenges for market growth. Emerging sequencing technologies threaten to disrupt the market through lower costs and higher capacity. Nonetheless, sanger sequencing is expected to remain relevant in niche applications that require long and accurate reads. Market players are focused on product portfolio expansion and geographic expansion through collaborations.

Key Features of the Study:

  • This report provides an in-depth analysis of the global sanger sequencing market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global sanger sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Eurofins Scientific, CeMIA, Fasteris SA, GENEWIZ , GenHunter Corporation, GenScript , LGC Biosearch Technologies, Nucleics , Quintara Biosciences, SciGenom Labs Pvt. Ltd, StarSEQ GmbH, Thermo Fisher Scientific Inc., QIAGEN, Promega Corporation, Source BioScience.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global sanger sequencing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sanger sequencing market.

Detailed Segmentation-

  • By Type:
    • Shotgun Sequencing
    • Targeted Gene Sequencing
    • Others
  • By Application:
    • Diagnostics
    • Personalized Medicine
    • Forensics
    • Others
  • By End-use:
    • Government Research Institutes
    • Diagnostic Labs
    • Pharmaceutical and Biotechnology Company
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Eurofins Scientific
    • CeMIA
    • Fasteris SA
    • GENEWIZ
    • GenHunter Corporation
    • GenScript
    • LGC Biosearch Technologies
    • Nucleics
    • Quintara Biosciences
    • SciGenom Labs Pvt. Ltd
    • StarSEQ GmbH
    • Thermo Fisher Scientific Inc.
    • QIAGEN
    • Promega Corporation
    • Source BioScience

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End-use
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Pricing Analysis
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Sanger Sequencing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 impact on the market

5. Global Sanger Sequencing Market, By Type, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Shotgun Sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Targeted Gene Sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Sanger Sequencing Market, By Application, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Personalized Medicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Forensics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Sanger Sequencing Market, By End-use, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Government Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Diagnostic Labs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pharmaceutical and Biotechnology Company
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Sanger Sequencing Market, By Region, 2019 - 2031, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Eurofins Scientific
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CeMIA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fasteris SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GENEWIZ
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GenHunter Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GenScript
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LGC Biosearch Technologies
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nucleics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Quintara Biosciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SciGenom Labs Pvt. Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • StarSEQ GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • QIAGEN
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Promega Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Source BioScience
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact